Inter- and intra-donor variability in bone marrow-derived mesenchymal stromal cells: implications for clinical applications

Background aims - Mesenchymal stromal cells (MSCs) are attractive as a therapeutic modality in multiple disease conditions characterized by inflammation and vascular compromise. Logistically they are advantageous because they can be isolated from adult tissue sources, such as bone marrow (BM). The p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Trivedi, Alpa (VerfasserIn) , Lin, Maximillian (VerfasserIn) , Miyazawa, Byron (VerfasserIn) , Nair, Alison (VerfasserIn) , Vivona, Lindsay (VerfasserIn) , Fang, Xiaohui (VerfasserIn) , Bieback, Karen (VerfasserIn) , Schäfer, Richard (VerfasserIn) , Spohn, Gabriele (VerfasserIn) , McKenna, David (VerfasserIn) , Zhuo, Hanjing (VerfasserIn) , Matthay, Michael A. (VerfasserIn) , Pati, Shibani (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: September 2024
In: Cytotherapy
Year: 2024, Jahrgang: 26, Heft: 9, Pages: 1062-1075
ISSN:1477-2566
DOI:10.1016/j.jcyt.2024.03.486
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jcyt.2024.03.486
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1465324924005711
Volltext
Verfasserangaben:Alpa Trivedi, Maximillian Lin, Byron Miyazawa, Alison Nair, Lindsay Vivona, Xiaohui Fang, Karen Bieback, Richard Schäfer, Gabriele Spohn, David McKenna, Hanjing Zhuo, Michael A. Matthay, Shibani Pati

MARC

LEADER 00000caa a2200000 c 4500
001 1906328099
003 DE-627
005 20241205181910.0
007 cr uuu---uuuuu
008 241021s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jcyt.2024.03.486  |2 doi 
035 |a (DE-627)1906328099 
035 |a (DE-599)KXP1906328099 
035 |a (OCoLC)1475316332 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Trivedi, Alpa  |e VerfasserIn  |0 (DE-588)1345591608  |0 (DE-627)1906328668  |4 aut 
245 1 0 |a Inter- and intra-donor variability in bone marrow-derived mesenchymal stromal cells  |b implications for clinical applications  |c Alpa Trivedi, Maximillian Lin, Byron Miyazawa, Alison Nair, Lindsay Vivona, Xiaohui Fang, Karen Bieback, Richard Schäfer, Gabriele Spohn, David McKenna, Hanjing Zhuo, Michael A. Matthay, Shibani Pati 
264 1 |c September 2024 
300 |b Illustrationen 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 30. März 2024, Artikelversion: 21. August 2024 
500 |a Gesehen am 21.10.2024 
520 |a Background aims - Mesenchymal stromal cells (MSCs) are attractive as a therapeutic modality in multiple disease conditions characterized by inflammation and vascular compromise. Logistically they are advantageous because they can be isolated from adult tissue sources, such as bone marrow (BM). The phase 2a START clinical trial determined BM-MSCs to be safe in patients with moderate-to-severe acute respiratory distress syndrome (ARDS). Herein, we examine a subset of the clinical doses of MSCs generated for the phase 2a START trial from three unique donors (1-3), where one of the donors’ donated BM on two separate occasions (donor 3 and 3W). - Methods - The main objective of this study was to correlate properties of the cells from the four lots with plasma biomarkers from treated patients and relevant to ARDS outcomes. To do this we evaluated MSC donor lots for (i) post-thaw viability, (ii) growth kinetics, (iii) metabolism, (iv) surface marker expression, (v) protein expression, (vi) immunomodulatory ability and (vii) their functional effects on regulating endothelial cell permeability. - Results - MSC-specific marker expression and protection of thrombin-challenged endothelial barrier permeability was similar among all four donor lots. Inter and intra-donor variability was observed in all the other in vitro assays. Furthermore, patient plasma ANG-2 and protein C levels at 6 hours post-transfusion were correlated to cell viability in an inter- and intra-donor dependent manner. - Conclusions - These findings highlight the potential of donor dependent (inter-) and collection dependent (intra-) effects in patient biomarker expression. 
650 4 |a ARDS 
650 4 |a bone marrow 
650 4 |a clinical trials 
650 4 |a donor variability 
650 4 |a mesenchymal stromal cells 
700 1 |a Lin, Maximillian  |e VerfasserIn  |4 aut 
700 1 |a Miyazawa, Byron  |e VerfasserIn  |4 aut 
700 1 |a Nair, Alison  |e VerfasserIn  |4 aut 
700 1 |a Vivona, Lindsay  |e VerfasserIn  |4 aut 
700 1 |a Fang, Xiaohui  |e VerfasserIn  |4 aut 
700 1 |a Bieback, Karen  |d 1972-  |e VerfasserIn  |0 (DE-588)124509991  |0 (DE-627)376254653  |0 (DE-576)294206604  |4 aut 
700 1 |a Schäfer, Richard  |e VerfasserIn  |4 aut 
700 1 |a Spohn, Gabriele  |e VerfasserIn  |4 aut 
700 1 |a McKenna, David  |e VerfasserIn  |4 aut 
700 1 |a Zhuo, Hanjing  |e VerfasserIn  |4 aut 
700 1 |a Matthay, Michael A.  |e VerfasserIn  |4 aut 
700 1 |a Pati, Shibani  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cytotherapy  |d New York, NY : Elsevier, 1999  |g 26(2024), 9 vom: Sept., Seite 1062-1075  |h Online-Ressource  |w (DE-627)341913596  |w (DE-600)2071176-1  |w (DE-576)273884557  |x 1477-2566  |7 nnas  |a Inter- and intra-donor variability in bone marrow-derived mesenchymal stromal cells implications for clinical applications 
773 1 8 |g volume:26  |g year:2024  |g number:9  |g month:09  |g pages:1062-1075  |g extent:14  |a Inter- and intra-donor variability in bone marrow-derived mesenchymal stromal cells implications for clinical applications 
856 4 0 |u https://doi.org/10.1016/j.jcyt.2024.03.486  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1465324924005711  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20241021 
993 |a Article 
994 |a 2024 
998 |g 124509991  |a Bieback, Karen  |m 124509991:Bieback, Karen  |d 60000  |d 63500  |d 60000  |e 60000PB124509991  |e 63500PB124509991  |e 60000PB124509991  |k 0/60000/  |k 1/60000/63500/  |k 0/60000/  |p 7 
999 |a KXP-PPN1906328099  |e 4600492560 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"name":{"displayForm":["Alpa Trivedi, Maximillian Lin, Byron Miyazawa, Alison Nair, Lindsay Vivona, Xiaohui Fang, Karen Bieback, Richard Schäfer, Gabriele Spohn, David McKenna, Hanjing Zhuo, Michael A. Matthay, Shibani Pati"]},"note":["Online verfügbar: 30. März 2024, Artikelversion: 21. August 2024","Gesehen am 21.10.2024"],"person":[{"given":"Alpa","display":"Trivedi, Alpa","role":"aut","family":"Trivedi"},{"given":"Maximillian","display":"Lin, Maximillian","role":"aut","family":"Lin"},{"role":"aut","family":"Miyazawa","given":"Byron","display":"Miyazawa, Byron"},{"display":"Nair, Alison","given":"Alison","family":"Nair","role":"aut"},{"display":"Vivona, Lindsay","given":"Lindsay","family":"Vivona","role":"aut"},{"family":"Fang","role":"aut","display":"Fang, Xiaohui","given":"Xiaohui"},{"role":"aut","family":"Bieback","given":"Karen","display":"Bieback, Karen"},{"role":"aut","family":"Schäfer","given":"Richard","display":"Schäfer, Richard"},{"display":"Spohn, Gabriele","given":"Gabriele","role":"aut","family":"Spohn"},{"display":"McKenna, David","given":"David","family":"McKenna","role":"aut"},{"given":"Hanjing","display":"Zhuo, Hanjing","role":"aut","family":"Zhuo"},{"role":"aut","family":"Matthay","display":"Matthay, Michael A.","given":"Michael A."},{"family":"Pati","role":"aut","given":"Shibani","display":"Pati, Shibani"}],"recId":"1906328099","id":{"eki":["1906328099"],"doi":["10.1016/j.jcyt.2024.03.486"]},"physDesc":[{"extent":"14 S.","noteIll":"Illustrationen"}],"title":[{"subtitle":"implications for clinical applications","title":"Inter- and intra-donor variability in bone marrow-derived mesenchymal stromal cells","title_sort":"Inter- and intra-donor variability in bone marrow-derived mesenchymal stromal cells"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"September 2024","dateIssuedKey":"2024"}],"relHost":[{"recId":"341913596","title":[{"title_sort":"Cytotherapy","subtitle":"official journal of ISCT, the International Society for Cellular Therapy","title":"Cytotherapy"}],"id":{"zdb":["2071176-1"],"issn":["1477-2566"],"eki":["341913596"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"Elsevier ; Isis Medical Media ; Taylor & Francis ; Informa Healthcare","dateIssuedDisp":"1999-","dateIssuedKey":"1999","publisherPlace":"New York, NY ; Oxford ; Basingstoke ; London [u.a.]"}],"language":["eng"],"part":{"issue":"9","pages":"1062-1075","extent":"14","text":"26(2024), 9 vom: Sept., Seite 1062-1075","year":"2024","volume":"26"},"pubHistory":["1.1999 -"],"note":["Gesehen am 04.02.20"],"disp":"Inter- and intra-donor variability in bone marrow-derived mesenchymal stromal cells implications for clinical applicationsCytotherapy","type":{"bibl":"periodical","media":"Online-Ressource"}}]} 
SRT |a TRIVEDIALPINTERANDIN2024